Share Fund
The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.
Suitability
This product is suitable for investors who are seeking
• Long term capital growth.
• Investment in equity and equity related securities of pharma and other associated companies.
Scheme Class | Equity |
Scheme Category | Sector - Healthcare |
Expense Ratio | 0.92% |
Min subscription | ₹ 5,000 |
Scheme Type | Open-ended |
Scheme AUM (in Crs.) | ₹ 8,140 |
AMC AUM (in Crs.) | ₹ 2,33,617 |
Min Addition Subscription | ₹ 1,000 |
Benchmark Type | S&P BSE Healthcare PR |
Exit Load | Exit load of 1.0%, if redeemed between (0-1) months. No Exit load, if redeemed after 1 months. |
Fund | Min SIP Inv. | Min Inv. | Returns 3Y |
---|---|---|---|
SBI Healthcare Opportunities Fund - Direct Plan | 0 | 0 | 23.37% |
SBI Healthcare Opportunities Fund - Direct Plan | 0 | 0 | 23.37% |
Nippon India Pharma Fund - Direct Plan | 1000 | 1000 | 19.61% |
UTI Healthcare Fund - Direct Plan | 0 | 0 | 20.65% |
Nippon India Pharma Fund - Direct Plan | 1000 | 1000 | 19.61% |
UTI Healthcare Fund - Direct Plan | 0 | 0 | 20.65% |
Company | Holding Type | Asset(%) |
---|---|---|
Sun Pharmaceuticals Industries Ltd | Equity | 14 |
Divi's Laboratories Ltd | Equity | 8 |
Lupin Ltd | Equity | 8 |
Cipla Ltd | Equity | 6 |
Dr Reddy's Laboratories Ltd | Equity | 6 |
Apollo Hospitals Enterprise Ltd | Equity | 5 |
Zydus Lifesciences Ltd | Equity | 4 |
Gland Pharma Ltd | Equity | 4 |
Ajanta Pharma Ltd | Equity | 3 |
Aurobindo Pharma Ltd | Equity | 3 |
Asset | Percent |
---|---|
Equity | 98 |
Cash - Repurchase Agreement | 2 |
Cash | 0 |
Cash - Collateral | 0 |
Sector | Percent |
---|---|
Healthcare | 97 |
Cash - Repurchase Agreement | 2 |
Equity | 1 |
Cash | 0 |
Cash - Collateral | 0 |
Fund Manager
Sailesh Raj Bhan
19+ years of experience
Kinjal Desai
6+ years of experience
About
customercare@nipponindiaim.in
Phone
18002090007
Address
Nippon Life India Asset Management Limited,4th Floor, Tower A, Peninsula Business Park,,Ganapatrao Kadam Marg,,Lower Parel (W), Mumbai - 400 013